-
New Research Partnership Pushes for Increased Transparency & Publication of Negative Research
November 2, 2020Null Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the…
-
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
October 19, 2020Cohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging…
-
Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data Prize
September 14, 2020The Global Preclinical Data Forum (GPDF), a jointly sponsored U.S. and European initiative, funded by Cohen Veterans Bioscience (CVB) and…
-
New Collaboration Gives Veterans Better Access To Innovative Research Trials
May 7, 2020Cohen Veterans Bioscience announced it is extending its commitment to the brain health of Veterans by supporting the National…
-
Global Preclinical Data Forum Announces 2020 Negative Data Prize Award
April 7, 2020This prize, which was first launched in 2017, will award €10,000 to the researcher/research group whose publication in neuroscience…
-
Cohen Veterans Bioscience Launches New Veterans Advisory Council (VAC) To Address Brain Health Priorities
February 13, 2020Cohen Veterans Bioscience announces its sponsorship for the formation of a Veterans Advisory Council (VAC) to ensure the delivery…
-
Traumatic Brain Injuries in Soldiers Need Immediate Attention & New Solutions
January 30, 2020Cohen Veterans Bioscience announces that traumatic brain injuries (TBIs) – the grossly understudied “invisible wounds” afflicting today’s soldiers –…
-
Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics
November 11, 2019Cohen Veterans Bioscience announced its strategic collaboration with Parexel Biotech, a new division of Parexel, for CVB’s adaptive platform…
-
Landmark Study Identifies Six Genetic Markers of Post-Traumatic Stress Disorder (PTSD) Risk
October 8, 2019Cohen Veterans Bioscience and the Stanley Center for Psychiatric Research at the Broad Institute at MIT and Harvard, announce…
-
Cohen Veterans Bioscience Issues National PTSD Awareness Day Progress Report
June 27, 2019Read our progress update on critical post-traumatic stress disorder (PTSD) programs, and proceedings from the first State of the…
Press Releases
